Medicenna Therapeutics (MDNAF) Stock Price, Quote, News & History

Medicenna Therapeutics Corp (MDNAF) Stock Price, Quote, News & History

MDNAFOTCQX

Trade with Public

$0.4518

0.01182.68%

At close: Apr 17, 5:00 PM EST

Key Statistics

Open

$0.46

$0.45

Volume / Avg.

16.18K / 78.29K

Day Range

$0.45 - $0.46

52 Wk Range

0.43 - 1.43

Market Cap

$37.69M

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

8.22

Recent Medicenna Therapeutics Corp News

Partner Content

The Spread of COVID-19 Has Caused Massive Volume Spikes In Securities On OTC Markets

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. The COVID-19 pandemic has led to dramatic changes in market behavior, as traders and investors try to grapple with the short-term and long-term implications of a pandemic.

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-18.44M

Investing Cash Flow (TTM)

2.00K

Financing Cash Flow (TTM)

-18.00K

Free Cash Flow (TTM)

-18.44M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

-18.46M

Valuation Metrics

Enterprise Value

$29.42M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

8.13

Earnings Yield % (TTM)

-24.76%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$0.05

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

-$70.00K

Total Cash

$10.61M

Debt to Equity

0.02

Issuance of Debt (TTM)

-$70.00K

Repayment of Debt (TTM)

-$70.00K

Key Statistics

Open

$0.46

$0.45

Volume / Avg.

16.18K / 78.29K

Day Range

$0.45 - $0.46

52 Wk Range

0.43 - 1.43

Market Cap

$37.69M

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

8.22

About

Sector

Health Care

Industry

Biotechnology

Medicenna Therapeutics Corp is a Canada-based immuno-oncology company. Its principal business activity is the development and commercialization of IL-2, IL-4, and IL-13 Superkines and Empowered Superkines for the treatment of cancer, inflammation, an...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Medicenna Therapeutics (MDNAF) stock?

You can purchase shares of Medicenna Therapeutics (OTCQX:MDNAF) through any online brokerage.

View our list of the best stock brokerages

Who are Medicenna Therapeutics (MDNAF) competitors?

There are no as such competitors for Medicenna Therapeutics.

What is the forecast, or price target, for Medicenna Therapeutics (MDNAF) stock?

There is no analysis for Medicenna Therapeutics to provide a consensus price target.

What is the current price for Medicenna Therapeutics (MDNAF)?

The stock price for Medicenna Therapeutics (OTCQX: MDNAF) is $0.4518 last updated April 17, 2026 at 2:59 PM EDT.

Does Medicenna Therapeutics (MDNAF) pay a dividend?

There are no upcoming dividends for Medicenna Therapeutics.

When is Medicenna Therapeutics (OTCQX:MDNAF) reporting earnings?

Medicenna Therapeutics does not have any upcoming earnings scheduled.

Is Medicenna Therapeutics (MDNAF) going to split?

There is no upcoming split for Medicenna Therapeutics.

What sector and industry does Medicenna Therapeutics (MDNAF) operate in?

Medicenna Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the OTCQX.

Key Statistics

Open

$0.46

$0.45

Volume / Avg.

16.18K / 78.29K

Day Range

$0.45 - $0.46

52 Wk Range

0.43 - 1.43

Market Cap

$37.69M

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

8.22

Recent Medicenna Therapeutics Corp News

Partner Content

The Spread of COVID-19 Has Caused Massive Volume Spikes In Securities On OTC Markets

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-18.44M

Investing Cash Flow (TTM)

2.00K

Financing Cash Flow (TTM)

-18.00K

Free Cash Flow (TTM)

-18.44M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

-18.46M

Valuation Metrics

Enterprise Value

$29.42M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

8.13

Earnings Yield % (TTM)

-24.76%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$0.05

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

-$70.00K

Total Cash

$10.61M

Debt to Equity

0.02

Issuance of Debt (TTM)

-$70.00K

Repayment of Debt (TTM)

-$70.00K

Key Statistics

Open

$0.46

$0.45

Volume / Avg.

16.18K / 78.29K

Day Range

$0.45 - $0.46

52 Wk Range

0.43 - 1.43

Market Cap

$37.69M

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

8.22

About

Sector

Health Care

Industry

Biotechnology

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Medicenna Therapeutics (MDNAF) stock?

You can purchase shares of Medicenna Therapeutics (OTCQX:MDNAF) through any online brokerage.

View our list of the best stock brokerages

Who are Medicenna Therapeutics (MDNAF) competitors?

There are no as such competitors for Medicenna Therapeutics.

What is the forecast, or price target, for Medicenna Therapeutics (MDNAF) stock?

There is no analysis for Medicenna Therapeutics to provide a consensus price target.

What is the current price for Medicenna Therapeutics (MDNAF)?

The stock price for Medicenna Therapeutics (OTCQX: MDNAF) is $0.4518 last updated April 17, 2026 at 2:59 PM EDT.

Does Medicenna Therapeutics (MDNAF) pay a dividend?

There are no upcoming dividends for Medicenna Therapeutics.

When is Medicenna Therapeutics (OTCQX:MDNAF) reporting earnings?

Medicenna Therapeutics does not have any upcoming earnings scheduled.

Is Medicenna Therapeutics (MDNAF) going to split?

There is no upcoming split for Medicenna Therapeutics.

What sector and industry does Medicenna Therapeutics (MDNAF) operate in?

Medicenna Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the OTCQX.